Member Info for Energyshares

You don’t want to be out.
You would be very brave to trade this stock before contracts.

Reports on the news that a massive Earthquake has hit Wetherby. Police and Fire Brigade were called but all they could find was Avacta’s affimer plant machinery going full pelt churning out affimer reagents.

No update from Medusa website yet, but looking at their existing clients I can see Affidx doing really well.

CPI
Location: 16 sites globally
Size: 2,500 employees

Connex One
Location: Manchester; with further offices in Nigeria and South Africa
Size: 170

“Lateral flow tests have a crucial role to play in helping our society and economy return to normal, and I am confident that the AffiDX® test will now play a significant part in this process.”

Over to you Boris……..

Was
Winner on Saturday
Winner today :)

Which Jeremy is it
You are the last one you little twat
Jeremy Clarkson
Jeremy Irons
Jeremy Kyle
Jeremy Hunt
Jeremy Paxman
Jeremy Bamber
Jeremy Beadle
Jeremy Corbyn
Jeremy Vine
Jeremy Twat

From results presentation.

Q16: Will you be providing the UKGov or any other government with the Affimers reagent for the creation of their own LFT?
The Company has no plans to license the Affimer reagents to the UK government at the present time.

Very interesting at this present time could this be the delay ???

Also never answered about other governments could this be the EU delay ???

My Luck
Read RNS’s all fact those licence agreements are all true.
No ramping just stating the obvious.

Now jog on where you came from......

Thanks Pod
Imagine Affidx starts selling all we can make and positive results from AVA6000 trial. Strap your self in.
I don’t like making SP predictions but I would enjoy watching a bidding war :)

If a hostile bid comes in for Avacta from one of the Big Pharma, they will have to have very deep pockets.

The Affimer platform is an alternative to antibodies derived from a small human protein. Despite their shortcomings, antibodies currently dominate markets, such as diagnostics and therapeutics, worth in excess of $100bn.

Avacta has 2 divisions
In house Therapeutic division potentially worth Billions.
In house Diagnostic division
Potentially worth Billions.
Plus also own IP for
pre|CISION™ & TMAC ™
drug conjugate.

There is also another 10 reasons why these multi nationals need to dig very deep because they would also own the licence agreements to this Super 10 list below.

1.
LG Chem have a licence with Avacta for LG Chem has potentially 8 new products.
2.
Daewoong x 2 Gene & stem cell targets with other targets in pipeline plus Affyxell joint venture.
3.
ADC x 3 undisclosed cancer targets and years of research.
4.
Astrea the rights to generate and develop Affimer reagents in-house for affinity separation. It also provides Astrea with an option to convert the agreement into an exclusive license could be worth billions.
5.
Moderna exclusive license agreement with respect to certain Affimer molecules for vaccines.
6.
POINT Biopharma Inc. Licence to access to Avacta’s pre|CISION™ technology for the development of tumour-activated radiopharmaceuticals.

The radiopharmaceutical market is expected to grow to $15 billion by 2025
7.
Biokit has the right to develop, manufacture and commercialise through original equipment manufacturer (OEM) partners a diagnostic immunoassay for this analyte.
8.
Bruker has a collaboration agreement with Avacta to further develop the potential for the BAMS COVID-19 test as a clinical IVD.
9.
Mologic partnership with Avacta provides a framework agreement for the future development of a pipeline of tests in a range of disease areas. The possibility of combining Avacta’s spike antigen test with Mologic’s nucleocapsid antigen-based technology.
10.
Abcam hold the patent to the nearest molecule to affimers affibodies which are as good as affimers with their recent collaboration with Avacta they will get to see the full power of Affimers.
https://gtr.ukri.org/project/B62E4643-BE4E-42AC-9AD0-A659947F2584

Now LG Chem,Daewoong and Moderna are all Big Pharma themselves and probably wouldn’t want their licence agreements being scrutinised by other Big Pharma,so we could end up with a multi company bidding war.

Congratulations to all PI’s who have held this far,but I can see this as being one of the best investments ever.

DYOR.........:)

I hope Avacta are at the forefront of the next pandemic.
Once Affidx is up and running didn’t AS say he could have new affimers ready within 12 weeks (100 days)as per this article.
How the world should prepare for the next pandemic.

https://www.gov.uk/government/speeches/how-the-world-should-prepare-for-the-next-pandemic

If MHRA has passed and AS RNS’s without any contracts signed, bed wetters will have a field day.
I think he we release both MHRA and a major contract at same time.

12 different boards copied and pasted same message, sad sad life.

In the meantime, the Company has continued its discussions with distributors and customers for the AffiDX® antigen test and does not anticipate that the error will cause a delay to first commercial sales of the product.

Well customers has to be large scale customers UK Gov and EU Govs or he wouldn’t bother mentioning customers.

Why would a Global company with a market cap of £3 billion want to get involved with a ELISA test that it’s own CO has stated they don’t expect much sales.

But ABCAM would love to be involved with the best LFT on the market..

Global distribution agreement with ABCAM plc to sell Avacta'sSARS-CoV-2 research ELISA1 Affimer® reagents

I think this is our global Affidx distribution partner.
AS has already said they were not pushing Elisa sales it was just a tool for worldwide Labs to use.

Quite clever if ABCAM have informed all their customers about the best ELISA on the market by a mile and a LFT using these affimers will be on the market very soon.
Sales should fly once released.

More to this ABCAM agreement watch this space.......

Alastair Wonderland

"Oh dear! Oh dear! I shall be too late!"

Just checked out their LinkedIn page they have a link with a company thermal solutions to sell their other antibody test.
This company based in Norway they have also posted a page to sell in Colombia.
Looks good for when they start selling Affidx.
https://lnkd.in/dRnrWXP

Avacta children “are we there yet”

I think he could be getting a knock on the door if he has pretended he was a Avacta employee.
Disclaimer on bottom of email.

This email and any files transmitted with it are confidential.If you are not the intended recipient,any reading,printing,storage,
disclosure, copying or any action taken in respect of this email is prohibited and may be unlawful.